CI Investments Inc. Sells 114,123 Shares of Colgate-Palmolive Company $CL

CI Investments Inc. cut its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 23.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 363,281 shares of the company’s stock after selling 114,123 shares during the period. CI Investments Inc.’s holdings in Colgate-Palmolive were worth $29,041,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Westside Investment Management Inc. increased its stake in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares in the last quarter. Copia Wealth Management bought a new stake in shares of Colgate-Palmolive during the third quarter worth $29,000. Vermillion & White Wealth Management Group LLC lifted its stake in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after acquiring an additional 155 shares during the period. Cloud Capital Management LLC acquired a new stake in Colgate-Palmolive in the third quarter worth about $30,000. Finally, MTM Investment Management LLC bought a new stake in Colgate-Palmolive during the 2nd quarter worth about $39,000. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In related news, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares in the company, valued at $1,018,691.15. This trade represents a 59.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares of the company’s stock, valued at $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 184,683 shares of company stock worth $17,486,693. 0.41% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CL has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research report on Sunday, February 1st. UBS Group raised their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Piper Sandler upped their price objective on Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Finally, Morgan Stanley raised their target price on Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Price Performance

Shares of CL opened at $95.34 on Wednesday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a market cap of $76.85 billion, a price-to-earnings ratio of 36.39, a PEG ratio of 4.39 and a beta of 0.28. The company’s fifty day simple moving average is $88.16 and its 200 day simple moving average is $82.85. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.91 earnings per share. On average, research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is 79.39%.

Key Stories Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate is expanding its AI push under Iraklis “Kli” Pappas to get employees using AI beyond basic tasks — a potential productivity and innovation catalyst that could help margin and SG&A efficiencies over time. The AI Evangelist Shaking Up a 220-Year-Old Toothpaste Maker
• Neutral Sentiment: NY Fed’s John Williams cautioned it’s too early to judge the Iran war’s economic impact — that leaves uncertainty about near‑term inflation and growth but does not yet force a clear re‑rating for defensive consumer names. Fed’s Williams: too early to assess Iran war impact on US economy
• Neutral Sentiment: Market strategists note the S&P reaction over the next few sessions will determine whether the sell‑off is transient; momentum there could affect broad multiples that support consumer staples valuations. History says this is the critical question for the S&P 500 over the next few days
• Negative Sentiment: Former Treasury Sec. Janet Yellen warned the Iran conflict could raise inflation and slow growth, making the Fed more reluctant to cut — a higher‑for‑longer rates backdrop can pressure defensive multiple expansion and consumer spending. Yellen says Iran conflict puts Fed on hold, complicates rate cuts
• Negative Sentiment: Analysts (UBS, Barclays) flag that the Iran escalation risks derailing several trades and raising credit/AI worries — the resulting risk‑off could reduce demand or margin flexibility for consumer packaged goods. Iran Conflict: Which trades & themes are most at risk? Iran escalation compounds AI and credit worries, Barclays’ Cau warns
• Negative Sentiment: Higher oil risk premia have pushed banks to lift targets for oil majors — good for energy names but a headwind for Colgate via higher packaging, freight and input costs if elevated oil persists. Chevron, Exxon price targets raised at BofA on increased oil risk premium

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.